The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The use of elevated circulating hepatocyte growth factor (HGF) level as a potential prognostic biomarker in locally advanced pancreatic cancer.
 
Hannah Johnson Roberts
Stock and Other Ownership Interests - Oxford Biomedica (I)
 
Jennifer Yon-Li Wo
No Relationships to Disclose
 
Beow Y. Yeap
No Relationships to Disclose
 
Christine A. Ulysse
No Relationships to Disclose
 
Janet E. Murphy
No Relationships to Disclose
 
Colin D. Weekes
Honoraria - Bayer; Celgene; Lilly; Merrimack
Consulting or Advisory Role - Celgene; Ipsen; Merrimack
Research Funding - Abbvie; AstraZeneca; Bayer; Celgene; Genentech/Roche; Gilead Sciences; Halozyme; Ipsen; Lilly; Millennium
Travel, Accommodations, Expenses - Bayer; Celgene; Lilly
 
David P. Ryan
Stock and Other Ownership Interests - Acworth Pharmaceuticals; MPM Capital; Thrive Earlier Detection Corp
Honoraria - Research to Practice; UpToDate
Consulting or Advisory Role - Gritstone Bio; Maverick Therapeutics; MPM Capital; Oncorus; TCR2 Therapeutics; Twentyeight-Seven Therapeutics
Research Funding - Stand up to Cancer (Inst)
Patents, Royalties, Other Intellectual Property - Johns Hopkins University Press; McGraw Hill Chapter Royalties
Expert Testimony - Boehringer Ingelheim
Other Relationship - TCR2 Therapeutics
 
Jeffrey William Clark
Research Funding - Pfizer (Inst)
 
Cristina R. Ferrone
No Relationships to Disclose
 
Keith D. Lillemoe
No Relationships to Disclose
 
Motaz Qadan
Consulting or Advisory Role - Olympus Medical Systems
 
Carlos Fernandez-del Castillo
No Relationships to Disclose
 
Rakesh K. Jain
Leadership - Amgen; Tekla Capital Management; Tekla Capital Management; Tekla Capital Management; Tekla Capital Management
Stock and Other Ownership Interests - Enlight Biosciences; Ophthotech; SynDevRx
Honoraria - Amgen
Consulting or Advisory Role - Chugai Pharma USA; Ophthotech; SPARC; SynDevRx
 
Theodore S. Hong
Consulting or Advisory Role - Merck; Novocure; Synthetic Biologics
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Intrinsic LifeSciences (Inst); Ipsen (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Tesaro (Inst)
 
Gabriel Dan Duda
Honoraria - Bayer; Bristol-Myers Squibb; Simcere
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst)